Biomarker signatures in cancer patients with and without venous thromboembolism events: a substudy of CASSINI

Cancer is associated with an increased risk of venous thromboembolism (VTE). In the CASSINI study, ambulatory cancer patients with a Khorana risk score ≥2 had a reduced risk of VTE while receiving rivaroxaban. This analysis used blood samples from CASSINI to compare biomarker levels between patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Khorana, Alok A., Barnard, John, Wun, Ted, Vijapurkar, Ujjwala, Damaraju, CV, Moore, Kenneth Todd, Wildgoose, Peter, McCrae, Keith R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864658/
https://www.ncbi.nlm.nih.gov/pubmed/34807979
http://dx.doi.org/10.1182/bloodadvances.2021005710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864658/
https://www.ncbi.nlm.nih.gov/pubmed/34807979
http://dx.doi.org/10.1182/bloodadvances.2021005710

Ejemplares similares